A Thorough Examination of the Recent Advances in Mass Spectrometry

Abstract

Mass spectrometry has become an essential tool in pharmaceutical analysis, revolutionizing drug development, quality assurance, and our understanding of complex biological systems. This review provides a comprehensive overview of recent advances in mass spectrometry for pharmaceutical analysis. We discuss the fundamentals of mass spectrometry, including ionization and mass analysis principles, as well as the various types of mass spectrometers used in pharmaceutical analysis. We explore high-resolution mass spectrometry (HRMS), tandem mass spectrometry (MS/MS), ambient ionization mass spectrometry, and mass spectrometry imaging (MSI), highlighting their applications in drug characterization, quantification, imaging, and biomarker discovery. Furthermore, we examine the challenges faced by mass spectrometry, such as matrix effects and data interpretation, and discuss emerging trends and future perspectives. By understanding the recent advancements and addressing the challenges, mass spectrometry can continue to drive advancements in pharmaceutical analysis and quality assurance.

Introduction

I. INTRODUCTION

Mass spectrometry Mass spectrometry (MS) has revolutionized the field of pharmaceutical analysis, offering powerful analytical capabilities for the identification, characterization, and quantification of compounds. Its applications span across drug development, quality assurance, and therapeutic monitoring, making it an essential tool in the pharmaceutical industry. This review aims to explore the recent advancements in mass spectrometry techniques and their implications in pharmaceutical analysis.[1]

A. Overview of Mass Spectrometry in Pharmaceutical analysis

Mass spectrometry is a versatile analytical technique that measures the mass-to-charge ratio of ionized molecules, providing valuable insights into their structure and composition. In pharmaceutical analysis, mass spectrometry enables the detection and identification of drug compounds, impurities, metabolites, and contaminants with high sensitivity and specificity. It has become an indispensable tool in various stages of the drug development process, including drug discovery, formulation optimization, and pharmacokinetic studies.[1]

B. Importance of Mass Spectrometry in drug development and quality assurance

Mass spectrometry is a versatile analytical technique that measures the mass-to-charge ratio of ionized molecules, providing valuable insights into their structure and composition. In pharmaceutical analysis, mass spectrometry enables the detection and identification of drug compounds, impurities, metabolites, and contaminants with high sensitivity and specificity. It has become an indispensable tool in various stages of the drug development process, including drug discovery, formulation optimization, and pharmacokinetic studies. The use of mass spectrometry in drug development and quality assurance is vital for ensuring the safety, efficacy, and quality of pharmaceutical products. In the early stages of drug development, mass spectrometry facilitates the identification and structural characterization of potential drug candidates. It aids in assessing their stability, degradation pathways, and compatibility with various formulations. During the manufacturing process, mass spectrometry is employed for quality control purposes, allowing the detection of impurities, contaminants, and degradants. It assists in verifying the consistency and purity of pharmaceutical products, ensuring compliance with regulatory standards.

Moreover, mass spectrometry plays a crucial role in therapeutic monitoring, enabling the quantification of drugs and their metabolites in biological samples. This information is valuable for understanding drug efficacy, optimizing dosage regimens, and assessing patient response. [2]

II. FUNDAMENTALS OF MASS SPECTROMETRY

Mass spectrometry operates on the principle of ionization and mass analysis, allowing for the identification and characterization of molecules based on their mass-to-charge ratio. This section provides an overview of the fundamental concepts and techniques employed in mass spectrometry, as well as the various types of mass spectrometers commonly used in pharmaceutical analysis. [3]

A. Principles of Ionization and Mass Analysis

In mass spectrometry, the first step involves the ionization of molecules, converting them into charged species. Different ionization techniques are utilized, including electrospray ionization (ESI), matrix-assisted laser desorption/ionization (MALDI), atmospheric pressure chemical ionization (APCI), and more.[3] These techniques enable the generation of gas-phase ions from the analyte molecules, which can then be manipulated and analyzed.

Following ionization, the mass analyzer separates the ions based on their mass-to-charge ratio (m/z). There are several types of mass analyzers, each with its unique principles and capabilities. Some commonly used mass analyzers include quadrupole, time-of-flight (TOF), ion trap, and magnetic sector analyzers. Each analyzer offers advantages in terms of mass resolution, mass accuracy, sensitivity, and dynamic range.[4]

B. Types of Mass Spectrometers used in Pharmaceutical Analysis

In pharmaceutical analysis, a variety of mass spectrometers are employed to address different analytical challenges. Here are some commonly used types:

1. Quadrupole Mass Spectrometer: This versatile mass spectrometer allows for selective ion filtering and fragmentation analysis using collision-induced dissociation (CID). It is widely used for quantitative analysis, targeted screening, and method development.
2. Time-of-Flight Mass Spectrometer (TOF-MS): TOF-MS measures the flight time of ions to determine their mass-to-charge ratio. It offers high resolution, sensitivity, and fast data acquisition, making it suitable for metabolomics, proteomics, and high-throughput screening.
3. Ion Trap Mass Spectrometer: Ion traps trap ions in a three-dimensional space using electric and magnetic fields. They offer capabilities such as MS/MS fragmentation, multiple reaction monitoring (MRM), and scan modes. Ion traps are advantageous for structural elucidation, targeted analysis, and qualitative screening.
4. High-Resolution Mass Spectrometer (HRMS): HRMS provides enhanced mass accuracy and resolving power, enabling the analysis of complex mixtures with high precision. It is particularly valuable for accurate mass measurement, elemental composition determination, and identification of unknown compounds.[5,6]

III. HIGH-RESOLUTION MASS SPECTROMETRY

High-resolution mass spectrometry (HRMS) has witnessed significant advancements in recent years, enabling precise and accurate analysis of pharmaceutical compounds. This section highlights the latest developments in HRMS instrumentation and explores its diverse applications in pharmaceutical analysis.[7]

A. Advancements in HRMS instruments

Modern HRMS instruments offer improved resolution, mass accuracy, and sensitivity, enhancing the capabilities of pharmaceutical analysis.

Some key advancements include:

1. Orbitrap Technology : Orbitrap mass analyzers provide exceptional resolution and mass accuracy. Recent developments have led to improved scan speeds, dynamic range, and sensitivity. These instruments are widely used in metabolomics, proteomics, and small molecule analysis.
2. Time-of-Flight (TOF) with Tandem Mass Spectrometry (TOF-MS/MS): Combining TOF analyzers with MS/MS capabilities allows for fast and sensitive analysis of complex samples. Recent advancements in TOF-MS/MS instruments have focused on enhancing sensitivity, resolution, and data acquisition speed.
3. Hybrid Instruments : Hybrid mass spectrometers, such as quadrupole - TOF (Q-TOF) and quadrupole - Orbitrap, offer the advantages of multiple mass analyzers. These instruments provide excellent sensitivity, selectivity, and mass accuracy, enabling comprehensive characterization of pharmaceutical compounds.[8]

B. Applications of HRMS in Pharmaceutical analysis

HRMS has found wide-ranging applications in pharmaceutical analysis, contributing to drug development, quality assurance, and therapeutic monitoring. Some key applications include:

1. Characterization of drug compounds: HRMS facilitates the identification and structural elucidation of drug compounds, including small molecules, peptides, and biologics. It enables the determination of accurate mass, elemental composition, and fragmentation patterns, aiding in the understanding of compound properties. [9]
2. Impurity profiling and degradation product analysis: HRMS plays a crucial role in the identification and quantification of impurities and degradation products in pharmaceutical formulations. It offers high sensitivity and selectivity, allowing for the detection of trace-level impurities and degradation pathways.
3. Metabolite identification and pharmacokinetic studies: HRMS enables the analysis of drug metabolism and pharmacokinetics. By identifying and quantifying drug metabolites in biological samples, HRMS aids in understanding drug clearance, metabolic pathways, and potential drug-drug interactions.
4. Doping control and sports drug testing: HRMS is extensively utilized in anti-doping laboratories for the detection of performance-enhancing substances and their metabolites. It offers high sensitivity, specificity, and the ability to detect a wide range of prohibited substances.[10,11]

By harnessing the power of high-resolution mass spectrometry, researchers and scientists can gain valuable insights into the structure, composition, and behaviour of pharmaceutical compounds. The advancements in HRMS instruments and their applications have revolutionized the field of pharmaceutical analysis, enabling more accurate and comprehensive characterization of drug compounds.

IV. TANDEM MASS SPECTROMETRY

Tandem mass spectrometry (MS/MS) has emerged as a powerful technique in pharmaceutical analysis, allowing for enhanced structural elucidation, quantification, and targeted analysis of compounds. This section explores the recent developments in MS/MS techniques and showcases their diverse applications in the field.[12]

???????A. Recent development in MS/MS Techniques

In recent years, significant advancements have been made in MS/MS techniques, improving their sensitivity, selectivity, and data acquisition capabilities. Some notable developments include:

1. Multiple Reaction Monitoring (MRM): MRM is a targeted analysis technique that selectively monitors predefined precursor-to-product ion transitions. Recent advancements have focused on expanding the number of monitored transitions, enhancing sensitivity, and improving the quantification accuracy for multiple analytes in complex matrices.
2. Data-Independent Acquisition (DIA): DIA techniques, such as Sequential Window Acquisition of all THeoretical fragment-ion spectra (SWATH), provide comprehensive and unbiased analysis of complex samples. Recent developments have focused on improving the selectivity, dynamic range, and data processing algorithms for DIA-based methods. [14]
3. Parallel Reaction Monitoring (PRM): PRM combines the advantages of MRM and high-resolution mass spectrometry, allowing for simultaneous quantification and structural elucidation. Recent advancements have focused on improving the mass resolution, scan speed, and data analysis workflows for PRM-based approaches.
4. Ion Mobility Spectrometry (IMS)-MS/MS: The integration of ion mobility spectrometry with MS/MS techniques has gained prominence, enabling the separation of ions based on their size, shape, and charge. Recent developments in IMS-MS/MS have focused on enhancing peak capacity, ion transmission, and the coupling of IMS with high-resolution mass analyzers.[13,15]

???????B. Applications of MS/MS in Pharmaceutical Analysis

MS/MS techniques find widespread applications in pharmaceutical analysis, offering solutions for quantification, structural elucidation, and targeted analysis of compounds. Some key applications include:

1. Quantification of Drugs and Metabolites: MS/MS techniques, particularly MRM-based approaches, are extensively utilized for the quantification of drugs and metabolites in biological samples. Their high sensitivity, selectivity, and dynamic range enable accurate and precise quantification in complex matrices. [16]
2. Structural Elucidation of Unknown Compounds: MS/MS techniques provide valuable information about the fragmentation patterns of molecules, facilitating the structural elucidation of unknown compounds. By analyzing the fragmentation spectra, researchers can deduce the chemical structure and confirm the identity of pharmaceutical compounds.
3. Targeted and Untargeted analysis in Drug Discovery and Formulation: MS/MS techniques are employed in targeted and untargeted analysis approaches for drug discovery and formulation. They aid in identifying potential drug candidates, profiling metabolites, evaluating drug stability, and optimizing formulations.
4. Metabolomics and Pharmacokinetics: MS/MS techniques play a crucial role in metabolomics and pharmacokinetic studies. They enable the identification and quantification of endogenous metabolites, as well as the characterization of drug metabolism pathways, bioavailability, and clearance.

The recent advancements in tandem mass spectrometry (MS/MS) techniques have revolutionized the field of pharmaceutical analysis, offering enhanced capabilities for structural elucidation, quantification, and targeted analysis of compounds. The applications of MS/MS span various aspects of drug development, from early-stage discovery to pharmacokinetic studies and formulation optimization. [17,18]

V. AMBIENT IONIZATION MASS SPECTROMETRY

Ambient ionization mass spectrometry has emerged as a powerful technique in pharmaceutical analysis, allowing for rapid and direct analysis of samples in their native state, without extensive sample preparation. This section provides an overview of ambient ionization techniques, their principles, recent advancements, and applications in pharmaceutical analysis. [19]

???????A. Overview of Ambient Ionization Techniques

Ambient ionization techniques enable the direct analysis of samples under ambient conditions, eliminating the need for traditional sample preparation steps such as extraction, separation, and chromatography. These techniques ionize analytes directly from the sample surface or the surrounding environment, generating gas-phase ions for subsequent mass spectrometric analysis. Some commonly used ambient ionization techniques include:

1. Desorption Electrospray Ionization (DESI): DESI utilizes a pneumatically assisted electrospray to generate charged droplets that interact with the sample surface, extracting and ionizing analytes. It allows for the analysis of diverse sample types, including solids, liquids, and tissues.
2. Direct Analysis in Real-Time (DART): DART employs a stream of energetic gas ions that interact with the sample surface, producing desorbed and ionized analytes. It is suitable for rapid analysis of various samples, including drugs, metabolites, and contaminants.
3. Paper Spray Ionization (PSI): PSI involves the direct sampling of analytes from a porous paper substrate, followed by electrospray ionization. It offers simplicity, portability, and low-cost analysis, making it suitable for point-of-care applications and field analysis.
4. Extractive Electrospray Ionization (EESI): EESI utilizes a solvent stream that interacts with the sample surface, extracting analytes and forming charged droplets for subsequent ionization. It enables the analysis of complex samples, including biological tissues and environmental matrices.[20,21]

???????B. Advancements and Applications of Ambient Ionization MS

In recent years, ambient ionization mass spectrometry techniques have undergone significant advancements, leading to improved performance and expanded applications. Some notable advancements include:

1. Enhanced Sensitivity and Selectivity: Advances in ionization sources, mass analyzers, and data acquisition methods have enhanced the sensitivity and selectivity of ambient ionization MS. Improved instrumental capabilities enable the detection and quantification of analytes at lower concentrations, even in complex matrices.[22]
2. Real-time Monitoring and Imaging: Recent developments have focused on enabling real-time monitoring and imaging capabilities in ambient ionization MS. This allows for the visualization of spatial distributions, dynamic processes, and in situ reactions, providing valuable insights into drug delivery, metabolism, and formulation.

???????C. Applications of Ambient Ionization MS Pharmaceutical analysis

Ambient ionization mass spectrometry has found diverse applications in pharmaceutical analysis, offering advantages such as rapid analysis, minimal sample preparation, and in situ monitoring.

Some key applications include:

1. Rapid Analysis of Solid Samples: Ambient ionization MS techniques enable direct analysis of solid samples, including tablets, powders, and polymers. This facilitates rapid quality control, counterfeit drug detection, and formulation optimization.
2. Direct Analysis of Biological Tissues: Ambient ionization MS allows for the direct analysis of biological tissues, enabling the detection and localization of drugs, metabolites, and biomarkers. This is valuable for pharmacokinetic studies, drug distribution analysis, and understanding drug-tissue interactions.
3. In situ Monitoring of Pharmaceutical Processes: Ambient ionization MS techniques offer the ability to monitor and analyze pharmaceutical processes in real time. This includes monitoring drug synthesis, formulation processes, and drug release kinetics, providing valuable insights for process optimization and quality control.

The recent advancements in ambient ionization mass spectrometry have revolutionized the field of pharmaceutical analysis by offering rapid, direct, and in situ analysis capabilities. These techniques have the potential to streamline drug development, enhance quality assurance, and provide valuable insights into drug behavior and interactions.[23]

VI. MASS SPECTROMETRY IMAGING (MSI)

Mass spectrometry imaging (MSI) has emerged as a powerful technique in pharmaceutical analysis, allowing for the visualization of the spatial distribution of drugs, metabolites, and biomolecules within tissues, formulations, and drug delivery systems. This section provides an overview of MSI techniques, recent advancements, and showcases its applications in pharmaceutical analysis.[24]

???????A. Introduction to MSI Techniques

MSI combines the power of mass spectrometry and spatial imaging, enabling the simultaneous acquisition of molecular information and spatial localization within a sample. By rastering an ionization source across the sample surface, MSI generates molecular maps that provide valuable insights into the distribution of pharmaceutical compounds and their metabolites. Some commonly used MSI techniques include:

1. Matrix-Assisted Laser Desorption/Ionization Imaging (MALDI-IMS): MALDI-IMS utilizes a laser to desorb and ionize molecules from a sample surface coated with a matrix. The resulting ions are then analyzed by mass spectrometry, generating spatially resolved molecular maps.
2. Secondary Ion Mass Spectrometry Imaging (SIMS-IMS): SIMS-IMS utilizes a focused ion beam to sputter and ionize molecules from the sample surface. The generated secondary ions are then analyzed by mass spectrometry, providing high spatial resolution and sensitivity.[24,25]
3. Desorption Electrospray Ionization Mass Spectrometry Imaging (DESI-MSI): DESI-MSI involves the use of an electrospray to generate charged droplets that interact with the sample surface, desorbing and ionizing molecules for mass spectrometric analysis. It offers rapid imaging capabilities and compatibility with diverse sample types.

???????B. Recent Advancements in MSI

Recent advancements in MSI have expanded its capabilities, improving spatial resolution, sensitivity, and data analysis workflows. Some notable advancements include:

1. High-Resolution MSI: Improved instrumental designs, such as higher spatial resolution mass spectrometers and finer rastering techniques, have led to enhanced spatial resolution in MSI. This enables the visualization of molecular distributions at subcellular levels, providing detailed insights into drug localization and interactions.
2. Metabolic Profiling and Imaging: Advancements in MSI have facilitated the analysis and imaging of endogenous metabolites within tissues. By combining MSI with advanced data analysis tools, researchers can gain a deeper understanding of metabolic pathways, biomarkers, and disease progression.
3. Multiplexed Imaging: Recent developments in MSI techniques have enabled the simultaneous analysis of multiple analytes within a single sample. This multiplexed imaging capability allows for the visualization of drug distributions, metabolites, and related compounds, providing a comprehensive view of the sample composition.[26]

???????C. Applications of MSI in Pharmaceutical Analysis

MSI has a wide range of applications in pharmaceutical analysis, offering valuable insights into drug distribution, formulation optimization, pharmacokinetics, and toxicology. Some key applications include:

1. Drug Distribution in Tissues: MSI enables the visualization of drug distribution within tissues, providing information on drug penetration, target engagement, and off-target effects. This is valuable for understanding drug efficacy, tissue-specific pharmacokinetics, and drug delivery optimization.
2. Pharmaceutical Formulation Analysis: MSI can be utilized to assess drug distribution within pharmaceutical formulations, including tablets, patches, and gels. It provides insights into drug uniformity, crystallinity, and formulation stability, aiding in formulation optimization and quality control.
3. Metabolite Mapping and Biomarker Discovery: MSI facilitates the mapping of endogenous metabolites and biomolecules within tissues, aiding in the discovery of biomarkers and understanding metabolic processes. This has implications in disease diagnosis, treatment monitoring, and personalized medicine.
4. Toxicology and ADME Studies: MSI allows for the investigation of drug metabolism, distribution, and excretion within tissues and organs. By mapping the distribution of drug metabolites and related biomarkers, researchers can gain insights into toxicological effects and drug clearance pathways.

The advancements in mass spectrometry imaging (MSI) have revolutionized the field of pharmaceutical analysis by offering spatially resolved molecular information. These techniques provide valuable insights into drug distribution, formulation optimization, and understanding complex biological processes.[27]

VII. CHALLENGES AND FUTURE PERSPECTIVES

Mass spectrometry has become an indispensable tool in pharmaceutical analysis, but it also presents certain challenges. This section highlights some of the key challenges and discusses the future perspectives that hold promise for overcoming these limitations and advancing the field.[28]

???????A. Limitations of Mass Spectrometry in Pharmaceutical Analysis

Despite its numerous advantages, mass spectrometry in pharmaceutical analysis faces certain limitations that should be acknowledged:

1. Matrix Effects: The presence of complex matrices, such as biological fluids or formulation excipients, can affect ionization efficiency, ion suppression or enhancement, and overall data quality. Addressing matrix effects is crucial for accurate and reliable analysis.
2. Quantitative Accuracy and Precision: Achieving accurate and precise quantification in complex samples can be challenging due to factors like matrix effects, ion suppression, and calibration strategies. Developing robust and standardized quantitative approaches is essential for reliable results.
3. Spatial Resolution in Imaging: While MSI offers valuable insights into drug distribution within tissues, achieving high spatial resolution can be technically demanding. Improving spatial resolution without sacrificing sensitivity and data acquisition time remains a challenge.
4. Data Processing and Interpretation: The vast amount of data generated by mass spectrometry requires advanced data processing and interpretation methods. Developing efficient algorithms and software tools for data analysis and interpretation is essential for extracting meaningful information.[29]

???????B. Emerging Trends and Future Directions

Despite the challenges, several emerging trends and future directions hold promise for the advancement of mass spectrometry in pharmaceutical analysis:

1. Advancements in Instrumentation: Continuous advancements in mass spectrometry instrumentation, including ion sources, mass analyzers, and detectors, are enhancing sensitivity, resolution, and speed. New technologies, such as high-resolution mass spectrometry and hybrid mass spectrometry systems, are pushing the boundaries of analytical capabilities.
2. Integrated Approaches: Integrating mass spectrometry with other analytical techniques, such as chromatography, spectroscopy, and imaging modalities, can provide complementary information and enhance the overall analysis. This integration allows for comprehensive characterization and deeper understanding of pharmaceutical samples.[30,31]
3. Advances in Sample Preparation: Improvements in sample preparation techniques, such as microextraction methods, miniaturized sample handling, and automation, are streamlining the workflow and reducing the complexity of sample preparation. These advancements contribute to higher throughput and more efficient analysis.
4. Data Analysis and Informatics: The development of advanced data analysis tools, machine learning algorithms, and informatics platforms is facilitating efficient data processing, visualization, and interpretation. These tools assist in pattern recognition, biomarker discovery, and decision-making in pharmaceutical analysis.
5. Emerging Applications: Mass spectrometry is expanding its applications beyond traditional drug analysis. Areas such as metabolomics, lipidomics, proteomics, and biopharmaceutical analysis are leveraging mass spectrometry techniques to gain deeper insights into complex biological systems and therapeutic interventions.

The future of mass spectrometry in pharmaceutical analysis is exciting, with ongoing advancements and innovative approaches addressing current limitations. By overcoming these challenges and embracing emerging trends, mass spectrometry will continue to play a pivotal role in drug development, quality assurance, and personalized medicine.[34]

Conclusion

In this review, we have explored the recent advances in mass spectrometry for pharmaceutical analysis. Mass spectrometry has proven to be a powerful analytical technique in the field of drug development, quality assurance, and understanding complex biological systems. Through its ability to provide highly sensitive and selective detection, as well as structural elucidation of compounds, mass spectrometry has revolutionized the way pharmaceutical analysis is conducted. We began by discussing the fundamentals of mass spectrometry, including the principles of ionization and mass analysis, as well as the various types of mass spectrometers commonly used in pharmaceutical analysis. We then delved into specific areas of advancement, including high-resolution mass spectrometry (HRMS) and tandem mass spectrometry (MS/MS), showcasing their applications in drug characterization, quantification, and structural elucidation. Ambient ionization mass spectrometry was introduced as a rapid and direct analysis technique, highlighting its applications in solid sample analysis, biological tissue imaging, and in situ monitoring of pharmaceutical processes. Furthermore, we explored mass spectrometry imaging (MSI) and its ability to visualize drug distribution in tissues, formulation analysis, and biomarker discovery. While mass spectrometry has achieved remarkable progress in pharmaceutical analysis, certain challenges persist. Matrix effects, quantitative accuracy, spatial resolution in imaging, and data processing and interpretation remain areas of focus for future advancements. However, with emerging trends such as improved instrumentation, integrated approaches, advanced sample preparation techniques, data analysis tools, and expanding applications, the future of mass spectrometry in pharmaceutical analysis appears promising.[35] In conclusion, mass spectrometry continues to be a cornerstone in pharmaceutical analysis, providing invaluable insights into the characterization, quantification, and imaging of drugs and related compounds. Its impact extends beyond drug development, enabling advancements in personalized medicine, biomarker discovery, and understanding complex biological processes. By harnessing the power of mass spectrometry and addressing the existing challenges, we can further unlock its potential in advancing pharmaceutical analysis and quality assurance. Continued collaboration between researchers, instrument manufacturers, and regulatory bodies will play a crucial role in shaping the future of mass spectrometry in the pharmaceutical industry.

References

[1] Gowda, G. N., & Djukovic, D. (2014). Overview of mass spectrometry-based metabolomics: opportunities and challenges. Mass Spectrometry in Metabolomics: Methods and Protocols, 3-12. [2] Urban, P. L. (2016). Quantitative mass spectrometry: an overview. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 374(2079), 20150382. [3] Hiraoka, K. (Ed.). (2013). Fundamentals of mass spectrometry (Vol. 8, pp. p-145). New York: Springer. [4] Kind, T., & Fiehn, O. (2010). Advances in structure elucidation of small molecules using mass spectrometry. Bioanalytical reviews, 2, 23-60 [5] Haag, A. M. (2016). Mass analyzers and mass spectrometers. Modern proteomics–sample preparation, analysis and practical applications, 157-169. [6] Hu, Q., Noll, R. J., Li, H., Makarov, A., Hardman, M., & Graham Cooks, R. (2005). The Orbitrap: a new mass spectrometer. Journal of mass spectrometry, 40(4), 430-443. [7] Liu, Y., D\'Agostino, L. A., Qu, G., Jiang, G., & Martin, J. W. (2019). High-resolution mass spectrometry (HRMS) methods for nontarget discovery and characterization of poly-and per-fluoroalkyl substances (PFASs) in environmental and human samples. TrAC Trends in Analytical Chemistry, 121, 115420. [8] Lucci, P., Saurina, J., & Núñez, O. (2017). Trends in LC-MS and LC-HRMS analysis and characterization of polyphenols in food. TrAC Trends in Analytical Chemistry, 88, 1-24. [9] Aydo?an, C. (2020). Recent advances and applications in LC-HRMS for food and plant natural products: A critical review. Analytical and bioanalytical chemistry, 412, 1973-1991. [10] Ma, J., Li, K., Shi, S., Li, J., Tang, S., & Liu, L. (2022). The application of UHPLC-HRMS for quality control of traditional Chinese medicine. Frontiers in Pharmacology, 13, 922488. [11] Tripathy, S., Verma, D. K., Thakur, M., Chakravorty, N., Singh, S., & Srivastav, P. P. (2022). Recent trends in extraction, identification and quantification methods of Centella asiatica phytochemicals with potential applications in food industry and therapeutic relevance: A review. Food Bioscience, 49, 101864. [12] McLafferty, F. W. (1981). Tandem mass spectrometry. Science, 214(4518), 280-287. [13] de Hoffmann, E. (1996). Tandem mass spectrometry: a primer. Journal of mass spectrometry, 31(2), 129-137. [14] Zehethofer, N., & Pinto, D. M. (2008). Recent developments in tandem mass spectrometry for lipidomic analysis. Analytica chimica acta, 627(1), 62-70. [15] Sleno, L., & Volmer, D. A. (2004). Ion activation methods for tandem mass spectrometry. Journal of mass spectrometry, 39(10), 1091-1112. [16] Vogeser, M. (2003). Liquid chromatography-tandem mass spectrometry–application in the clinical laboratory. [17] Kushnir, M. M., Rockwood, A. L., & Bergquist, J. (2010). Liquid chromatography–tandem mass spectrometry applications in endocrinology. Mass spectrometry reviews, 29(3), 480-502. [18] Carpenter, K. H., & Wiley, V. (2002). Application of tandem mass spectrometry to biochemical genetics and newborn screening. Clinica chimica acta, 322(1-2), 1-10. [19] Huang, M. Z., Yuan, C. H., Cheng, S. C., Cho, Y. T., & Shiea, J. (2010). Ambient ionization mass spectrometry. Annual review of analytical chemistry, 3, 43-65. [20] Feider, C. L., Krieger, A., DeHoog, R. J., & Eberlin, L. S. (2019). Ambient ionization mass spectrometry: recent developments and applications. Analytical chemistry, 91(7), 4266-4290. [21] Huang, M. Z., Cheng, S. C., Cho, Y. T., & Shiea, J. (2011). Ambient ionization mass spectrometry: a tutorial. Analytica chimica acta, 702(1), 1-15. [22] Monge, M. E., & Fernández, F. M. (2014). An introduction to ambient ionization mass spectrometry. Ambient ionization mass spectrometry, 1-22. [23] Rankin?Turner, S., & Heaney, L. M. (2021). Applications of ambient ionization mass spectrometry in 2020: An annual review. Analytical Science Advances, 2(3-4), 193-212. [24] van Hove, E. R. A., Smith, D. F., & Heeren, R. M. (2010). A concise review of mass spectrometry imaging. Journal of chromatography A, 1217(25), 3946-3954. [25] Buchberger, A. R., DeLaney, K., Johnson, J., & Li, L. (2018). Mass spectrometry imaging: a review of emerging advancements and future insights. Analytical chemistry, 90(1), 240. [26] Bartels, B., & Svatoš, A. (2015). Spatially resolved in vivo plant metabolomics by laser ablation-based mass spectrometry imaging (MSI) techniques: LDI-MSI and LAESI. Frontiers in Plant Science, 6, 471. [27] He, M. J., Pu, W., Wang, X., Zhang, W., Tang, D., & Dai, Y. (2022). Comparing DESI-MSI and MALDI-MSI mediated spatial metabolomics and their applications in cancer studies. Frontiers in Oncology, 12, 891018. [28] Fricker, L. D. (2015). Limitations of mass spectrometry-based peptidomic approaches. Journal of the American Society for Mass Spectrometry, 26(12), 1981-1991. [29] Vaysse, P. M., Heeren, R. M., Porta, T., & Balluff, B. (2017). Mass spectrometry imaging for clinical research–latest developments, applications, and current limitations. Analyst, 142(15), 2690-2712. [30] Wang, J., et al. (2019). High-resolution Mass Spectrometry for Drug Characterization: Current Status and Future Trends. Analytical Chemistry, 91(8), 4807-4816. [31] Jones, E. F., et al. (2019). Integrating Mass Spectrometry with Chromatography Techniques for Comprehensive Pharmaceutical Profiling. Rapid Communications in Mass Spectrometry, 33(15), 1259-1268. [32] Brown, D. G., et al. (2018). Automated Sample Preparation for High-throughput Mass Spectrometry-based Drug Analysis. Analytical Chemistry, 90(6), 3796-3803. [33] Li, M., et al. (2018). Expanding Applications of Mass Spectrometry in Metabolomics and Lipidomics. Metabolites, 8(2), 17. [34] Garcia, M. R., et al. (2019). Applications of High-Resolution Mass Spectrometry in Drug Development and Metabolite Profiling. Analytical Chemistry, 91(6), 3897-3905.

Copyright

Copyright © 2023 Akshay Dogra, Himanshu Sharma, Upasana Thakur, Amar Deep Ankalgi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.